chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pain in hands; neck pain; swelling in my left ankle; stiffness; unable to walk; inability to stand; pain in hip; type 4 type reaction; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in hands), NECK PAIN (neck pain), JOINT SWELLING (swelling in my left ankle), MUSCULOSKELETAL STIFFNESS (stiffness) and GAIT INABILITY (unable to walk) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product RIMEGEPANT SULFATE (NURTEC ODT) for Migraine.    Concurrent medical conditions included Migraine.   On 11-Mar-2021, the patient started RIMEGEPANT SULFATE (NURTEC ODT) (Oral) 1 dosage form. On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (pain in hands), NECK PAIN (neck pain), JOINT SWELLING (swelling in my left ankle), MUSCULOSKELETAL STIFFNESS (stiffness), GAIT INABILITY (unable to walk), DYSSTASIA (inability to stand), ARTHRALGIA (pain in hip) and HYPERSENSITIVITY (type 4 type reaction). The patient was treated with PREDNISONE for Joint pain, at a dose of 1 dosage form and METHOTREXATE for Adverse event, at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (pain in hands), NECK PAIN (neck pain), JOINT SWELLING (swelling in my left ankle), MUSCULOSKELETAL STIFFNESS (stiffness), GAIT INABILITY (unable to walk), DYSSTASIA (inability to stand), ARTHRALGIA (pain in hip) and HYPERSENSITIVITY (type 4 type reaction) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No any concomitant medications were reported.  Patient's Lab test- All test for Rheumatoid arthritis- Negative.
sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In February 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were reported as follows: The patient experienced sore arm after 1st dose of vaccine which resolved within few days. The reporter consented to follow up. This case is linked with case US2020181859, reported by same reporter for same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020181859:same reporter
First weight lifting session after vaccination (6 days post injection in left deltoid) significant muscle weakness noticeable.  13 days post injection, notable atrophy in left triceps and pectoral muscles along with continued weakness. Pectoral and triceps muscles on the right side remain normal size and strength.
ERYTHEMA DEVELOPED AROUND SITE OF IMMUNIZATION ON LEFT LEG.  NO SYSTEMIC S/SX.  DX'D AS CELLULITIS VS. ALLERGIC REACTION.  STARTED ON BACTRIM ON 9/3/10.  RECHECKED 9/7/10 IMPROVED/ALMOST RESOLVED.
herpes zoster; Information has been received from a lawyer and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapy were not reported. On or about 19-OCT-2017, patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, lot # and expiration date were not reported) vaccine for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving zoster vaccine live (ZOSTAVAX) vaccine, patient suffered herpes zoster. As a result of these symptoms, patient was seen and treated by medical providers and is still under their care. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccine, patient's symptoms have resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX). Patients also experience mental and emotional distress due to resulting physical limitations and seriousness of Patients' condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), patients sustained severe and permanent personal injuries. Further, as a tragic consequence of company's wrongful conduct, patients suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of company's conduct, patients have suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of herpes zoster was reported as not recovered. The reporter considered herpes zoster to be related to zoster vaccine live (ZOSTAVAX).
Dizziness, Lightheadedness, Extreme Nausea, vomiting, Chest Hurting, Diarrhea
Patient has softball sized red hard area at site of DTaP injection.  Using ice packs.  No pain with ambulation.  Afebrile after infection.
Was seen in the morning at my office for 2 month check, exam normal.  Gave immunizations at the end of the visit.  Was called by ER at about 1:30 PM that the patient arrived in the ER deceased.
Recurring cystic rash on Lt side of torso. Remains until treated with antibiotics. Civilian doctor cannot pinpoint cause. After exam and blood tests, doctor thinks it may be an immune system disorder. Condition first began in 6/00.
Client reported on COVID vaccine screening form that he had not received any prior COVID vaccine and confirmed this to RN.  Dose 1 of Pfizer administered.  After administration, 1 prior dose of Moderna administered 4/24/21. Client contacted and reported no adverse effects.  Was advised by this RN (following consult with program medical director) that he had received a mixed series, that no further doses of covid vaccine recommended at this time but that no data on efficacy of mixed dose series is available.  Client reported understanding and had no questions or concerns.  Will call clinic or RN  if further question.
w/in 24hr of vax pt had a near syncopal episode followed by weakness, myalgias neck & shoulder stiffness & fever to 103;pt had n/v when temp was elevated;
ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 7/14/2022,  9/15/2022,  9/16/2022,  12/10/2022  --  RECURRENCE OF SAME SYMPTOMS
2 of her friends who took the vaccine got pancreatic cancer within 3 months after taking the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PANCREATIC CARCINOMA (medically significant), outcome "unknown", described as "2 of her friends who took the vaccine got pancreatic cancer within 3 months after taking the vaccine".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201032213 same reporter/drug/AE, different patient;
She is now experiencing a fever of 99.5 degrees; sneezing, nose is running, she feels like she has head colds; sneezing, nose is running, she feels like she has head colds; sneezing, nose is running, she feels like she has head colds; This is a spontaneous report from a Pfizer sponsored program. A contactable female consumer (patient) of an unspecified age received bnt162b2 (BNT162B2 Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 23Apr2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021 patient was experiencing a fever of 99.5 degrees, sneezing, nose is running, she feels like she has head colds, but she never had colds for years. The patient underwent lab tests and procedures which included pyrexia: 99.5 degree. No unaddressed medical questions referred or forwarded to Medical Information. The outcome for all events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
lot of fever; lot of pain on my arm; body chills; felt very tired; was not feeling very well, I felt bad the whole day; was not feeling very well, I felt bad the whole day; slept the whole day and night; This is a spontaneous report from a contactable consumer. This 36-year-old consumer (patient) reported.  A 36-years-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: ER8733), via an unspecified route of administration, administered in Left arm on 30Mar2021 (at the age of 36-years-old) as dose number unknown, single for covid-19 immunisation. The patient medical history was reported as none. The patient's concomitant medications were none. On 31Mar2021, the patient experienced lot of fever, lot of pain on my arm, body chills, felt very tired, was not feeling very well, I felt bad the whole day and slept the whole day and night. The reporter stated that reporter had the COVID vaccine on 30Mar2021, around 5 pm, 5:30 more or less and patient had a lot of fever 31Mar2021 and had a lot of pain in arm, fever and body chills and felt very tired and when it was around 9pm, 8:30, I 8 O'clock, 8, the patient took ibuprofen, 2 tablets of Ibuprofen(treatment) of 20 Millimeter (further clarification unknown). The reporter stated, "Today I feel better but yesterday I was not feeling very well, I felt bad the whole day, I slept the whole day and night I needed to do some work for my university so, after I ate, I decided to take the 2 Ibuprofen of 200 Millimeter, more or less it was already 24 hours after I took the vaccine. The patient took 2 Ibuprofen tablets of 200 millimeter as therapeutic measures for events. The clinical outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Pt received varicella vaccine on 12/20/1996. Skin rash appeared on 06/13/02. She was diagnosed with varicella on 06/14/02. Small erythematous papules were distributed on chest wall, back, upper arms (total < 20).
This was the second booster (not bivalent) so her 4th dose total and first three were Moderna; This was the second booster (not bivalent) so her 4th dose total and first three were Moderna; Vertigo; nausea; lightheaded; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A 54-year-old female patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient didn't receive BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5). The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Moderna (DOSE 1), for COVID-19 immunization; Moderna (DOSE 2), for COVID-19 immunization; Moderna (DOSE 3 (BOOSTER)), for COVID-19 immunization. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious), WRONG PRODUCT ADMINISTERED (non-serious), outcome "unknown" and all described as "This was the second booster (not bivalent) so her 4th dose total and first three were Moderna"; VERTIGO (non-serious), outcome "unknown"; NAUSEA (non-serious), outcome "unknown"; DIZZINESS (non-serious), outcome "unknown", described as "lightheaded". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patent weight 157.4 and height was 5.41/2. Patient had Vertigo/nausea/ lightheaded for 3 months. Events took place after use of product.  The information on the batch/lot number for BNT162b2, BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Driving my car on route 50 in morning of the 6th, felt fine after getting up showering and getting ready for work.  About 10 miles to my destination I felt naueous and completed fainted at the wheel.  I then hit a guard rail on the right and I can only assume I pulled the wheel to the left and hit the guard rail there.  I was very lucky I did't hit another car or I wasn't hit myself by another car.  This road is very busy all the time.  I then got myself together and pulled off to a place where I could evaluate my situation.  Someone came to my aid as I tried to remove myself from the drivers side door, which was dented in.  The called 911 and I was taken to the hospital. The did a number of tests and I was told that I was fine.  I have had no re-occurrences and have no history of fainting.  I did about 15,000 of damage to my car.
irregular period; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient in her 30's received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE, Manufacturer: unknown), for COVID-19 immunization. The following information was reported: MENSTRUATION IRREGULAR (non-serious), outcome "unknown", described as "irregular period".  Additional information: Late 30s female, otherwise healthy, reported irregular period since second COVID vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After 3 days of receiving Moderna I started spilling ketones. My blood glucose levels remained in normal range even though I was spilling ketones. I continued to spill ketones for 3 days. When I had my period 3 weeks after first dose of Moderna  it was heavier and longer than normal.
pt given varicella vax 1/22/99, devel chickenpox 11/29/99,adm to hosp 12/8/99 w/croup (neg rsv) 1 bro w/chickenpox at same time, 1 bro and mom devel chickenpox 12/6. all unvax, mom had chickenpox as child.
I just really got dizzy to point  I felt like my head was swimming. I could not lay on my back, that also cause dizziness. I also broke out in sweats in the middle of the night.
Td booster given 1/29/03. Beginning 1/31/03 area became reddened, swollen and warm to touch from injection site to elbow. Today 20mm site of injection with warmness noted to touch.
First dose 15-Apr-2021 and second dose on 05-Jul-2021; Since May 2021 I have had no lumps under my right arm. Since August 2021 I have had no lumps under my left arm.; This spontaneous case was reported by a patient and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Since May 2021 I have had no lumps under my right arm. Since August 2021 I have had no lumps under my left arm.) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose 15-Apr-2021 and second dose on 05-Jul-2021) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Concurrent medical conditions included Hidradenitis suppurativa (Patient had it from29 years, under both arms (armpits) and groin.).   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Since May 2021 I have had no lumps under my right arm. Since August 2021 I have had no lumps under my left arm.). On 05-Jul-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose 15-Apr-2021 and second dose on 05-Jul-2021). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Since May 2021 I have had no lumps under my right arm. Since August 2021 I have had no lumps under my left arm.) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose 15-Apr-2021 and second dose on 05-Jul-2021) outcome was unknown.            Patient reported taking Antibiotics 4 times a day as patient still was suffering with the lumps in groin.  The patient had reported have been suffering with Hidradenitis Suppurativa for 29 years. Its under both arms (armpits) and groin. Patient reported  since May-2021, patient had no lumps under right arm and since Aug-2021 patient had no lumps under left arm. Patient was still suffering with the lumps in groin. Patient had the sweat glands removed from groin already.  Treatment information was not reported.
Pt reports dizziness and nausea, guardian elected to recover at home post 30 minutue observation.
This case was reported by a nurse via a wholesaler sales representative and described the occurrence of low seroconversion to hepatitis b vaccine in a subject of unspecified age and gender who was vaccinated with Engerix-B for prophylaxis. It was thought that the subject completed the entire series of Engerix-b (vaccination dates not provided), but it was unclear. At an unspecified time after vaccination with Engerix-B, the subject's titer did not reach the correct level, and the subject developed possible lack of efficacy. At the time of reporting, the outcome of the events was unspecified.
A report has been received from a health professional concerning a 13 year old male patient. Concomitant medications and patient history were not reported. During autumn 2011 the patient received nasal FLUMIST. After that he experienced severe symptoms of flu, chills, migraines, fatigue and headache. The outcome of the events was unknown. The report was considered to be non-serious by company physician.
positive COVID-19 test with symptoms; positive COVID-19 test with symptoms; This is a spontaneous report from a contactable consumer who reported for her husband via a Pfizer Sponsored Program, Pfizer First Connect. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The reporter stated that "her husband received the first shot and tested positive for COVID-19. Her husband had fever, colds and sore throat." The reporter wanted to know if her husband could still receive the 2nd dose of the vaccine. The clinical outcome of the event "positive COVID-19 test with symptoms" was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded.  The case will be reassessed if additional information becomes available.
After arriving at our clinic for her second Moderna COVID vaccine, patient reports being allergic to her first dose of Moderna COVID vaccine. Patient reports going to the emergency room later that same day, 4/20/21, for swelling of her throat and "all of her insides." Additionally, she had trouble breathing. Patient was denied her second dose of Moderna COVID vaccine at this time.
Raised rash starting on one leg 7/24/03 then both and day after rash on arms, legs and trunk. Rash more generalized-less raised. Thursday 7/24/03 had fever of 102 degrees-normal on 7/25/03. Child feeling better day 2 of adverse event.
headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was reported No treatment information was reported
This is a 66-year-old female past history of asthma, COPD, carotid stenosis who presents with a COVID-19 vaccine side effect.  Patient states she got her second Covid vaccine this morning and shortly thereafter noticed numbness in her left arm.  She states that the numbness is directly in line with the injection location.  She states it has not improved nor worsened over the course of the day.  She still has strength in her left upper extremity.  She states that within the first hour or 2 after injection and she noted some perioral numbness.  She states that her lips were tingling and then she noted on her cheeks and then down the sides of her neck.  She states she never had any difficulty swallowing or difficulty breathing.  She states that she became concerned because this is very atypical for her as she has never had paresthesias in these locations.  Patient states that she was encouraged by her doctor to come to the emergency department.  Over the past 10 hours that she has been in the waiting room her facial symptoms have improved.  She states that her lips only now feel like she is "coming back from Novocain ".  She states that she no longer has the facial paresthesias no other paresthesias in her neck.  She states that the paresthesias in her arm are unchanged.  She denies any fever, chills, nausea, vomiting, dizziness, urticaria, facial swelling, oral swelling, pharyngeal swelling.  Facial paresthesias are bilateral and without droop of the face.
Patient received COVID vaccine and was advised to wait 15 minutes. 5 minutes later, the patient's wife comes asking for water and stated the patient was feeling dizzy. I approached the patient and asked questions regarding symptoms and he stated he "lost consciousness" for a few seconds and was sweating. I waited with the patient for 10+ minutes and asked if his symptoms were getting better. I made sure he was awake and responsive. The patient stated he was feeling tingly and "amphetamine-like effect." A few minutes later he was pouring the water on his head and decided to lay on the ground. Based on his response, I called 911. After paramedics arrived and checked his condition, his symptoms improved. Based on discussion with paramedics, it looked to be like a panic attack to vaccination.
RECEIVED PNEUMONIA VACCINE IN RIGHT ARM I.M. NO BRUSING PAIN OR ITCHING.DOESN'T WANT TO GO TO DR.. WS INFORMED TO GO TO DR.. 5MM. PATCH RASH ON UNDERSIDE AND LATERAL INSIDE FOREARM. HAD VACCINE 5 YEARS AGO AND WAS INSTRUCTED PER DR TO GET ANOTHER.
High-pitched cry for 1.5 hours (never again before or since). Stopped babbling for about 6-12 weeks and got a twitch in left shoulder that still continues. Diagnosed with autism at 2 years.